IN8BIO, INC.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
EMPIRE STATE BUILDING, NEW YORK, NY, 10118
Mailing Address
EMPIRE STATE BUILDING, NEW YORK, NY, 10118
Phone
(646) 600-6438
Fiscal Year End
1231
EIN
825462585
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| DEF 14A Definitive proxy statement | March 26, 2026 | View on SEC |
| 10-K Annual financial report | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 12, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 2, 2026 | View on SEC |
| 8-K Current report of material events | February 27, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 17, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
Annual Reports
10-K
March 12, 2026
- Advancing innovative gamma-delta T cell therapies (INB-100, INB-200) in Phase 1 clinical trials for glioblastoma and solid tumors.
- Strategic focus on core clinical assets after pipeline prioritization, aiming to maximize success with limited resources.
Related Companies
Companies in the same industry (SIC: 2836)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX
Biological Products, (No Diagnostic Substances)
Hemab Therapeutics Holdings, Inc.
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
MESOBLAST LTD
MESO
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.